March 15, 2014 11:29 (IST)
The Corporate Debt Restructuring Empowered Group (CDR EG) has approved Orchid Chemicals and Pharmaceuticals' debt restructuring proposal, the pharma company said on Friday.
March 14, 2014 19:06 (IST)
This followed a series of actions by the USFDA, which in 2008 banned the import of 30 generic drugs produced by Ranbaxy at the two plants for violation of manufacturing norms.
March 13, 2014 22:54 (IST)
Foreign brokerage firm Barclays has said in a research report that an import alert (IA) on Sun Pharma's Karkhadi plant by the US Food and Drug Administration (FDA) will have a negligible impact.
Mumbai | March 12, 2014 14:55 (IST)
Global drug makers have had a nauseous time in India's $14-billion market. Prices have dropped and valuable patents have been overruled as the authorities strive to make medicines affordable for the 70 per cent of people living on less than $2 a day.
March 11, 2014 15:48 (IST)
The source declined to give details and refused to be named due to the sensitivity of the issue.
Mumbai | March 10, 2014 09:33 (IST)
Ranbaxy confirmed the recall of select batches of the drug, a generic version of Pfizer Inc's Lipitor, but said the company had not received any product complaints.
Mumbai | March 08, 2014 14:02 (IST)
Ranbaxy recalled tablets of atorvastatin calcium, the generic version of Pfizer Inc's cholesterol fighter Lipitor, after a pharmacist found a 20-milligram tablet in a sealed bottle marked for 10-milligram tablets, the US Food and Drug Administration (FDA) said on its website.
New Delhi/ Mumbai | March 06, 2014 16:29 (IST)
An Indian committee is reviewing up to a dozen patented drugs to see if so-called compulsory licences, which in effect break exclusivity rights, can be issued for some of them, two senior government officials said last month.
March 06, 2014 14:47 (IST)
Sun Pharmaceutical Industries, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of low-cost drugs, a senior executive said.
Hyderabad | March 05, 2014 14:34 (IST)
The drug was launched yesterday following the approval by the United States Food & Drug Administration (USFDA), DRL said in a press release today.
February 26, 2014 16:53 (IST)
The approval from the US Food and Drug Administration is for Rifabutin Capsules USP, in strength of 150 mg, said Lupin in a statement.
February 25, 2014 22:34 (IST)
The injection is an auto-injector system for subcutaneous use. It is a therapeutic equivalent generic version of Imitrex Statdose Pen (sumatriptan succinate) and was launched in the US market today following approval by the United States Food & Drug Administration (USFDA), a company statement said.
Mumbai | February 25, 2014 07:45 (IST)
The Toansa and Dewas plants are currently banned from shipping products to the United States following quality concerns, so the suspension will hit supplies to other markets including Europe and India, two people with knowledge of the matter said.
February 24, 2014 14:32 (IST)
Pfizer East India B.V. Netherlands will buy a 29.52 percent stake in Pfizer Ltd from Pfizer Investments Netherlands B.V's for Rs 1,537 a share.
Washington | February 22, 2014 12:47 (IST)
The head of the US Food and Drug Administration said on Friday it was not unduly targeting drug companies in India, which supplies a large portion of drugs used in the US, as the agency cracks down on substandard medication from abroad.
February 20, 2014 17:03 (IST)
Commenting on the development, MSD in India Managing Director K G Ananthakrishnan said the partnership is aligned with the company's commitment towards patients in India.
February 18, 2014 16:09 (IST)
Hamburg also urged Indian regulators to work closely with their foreign peers.
New Delhi | February 18, 2014 13:06 (IST)
Pharma major Lupin today appointed ex-Teva executive Maurice Chagnaud as its president, Europe and head of inhalation strategy.
February 16, 2014 15:21 (IST)
Pharmaceutical sales in India are expected to rise by 14.4 per cent to $27 billion in 2016 from last year, but the life sciences and health care industry is up against challenges such as quality management and meeting global standards, consultancy firm Deloitte said in a report.
Washington | February 15, 2014 14:46 (IST)
American pharma companies and their advocacy groups today rued at the alleged restrictive India policies on clinical research, saying such policies are harming the companies.